Previous Article | Next Article ![]()
Journal of Virology, August 2001, p. 6977-6988, Vol. 75, No. 15
Molecular and Cellular Biology, Faculty of
Agronomy, Gembloux,1 Hormone and Metabolic
Research Unit, Institute of Cellular Pathology and
Université de Louvain, Brussels,2
Department of Molecular Biology,3 and
IRIBHN,4 IBMM, ULB, Gosselies, and
Department of Virology, Veterinary and Agrochemical Research
Centre, Uccle,5 Belgium
Received 29 January 2001/Accepted 4 May 2001
Repression of viral expression is a major strategy developed by
retroviruses to escape from the host immune response. The absence of
viral proteins (or derived peptides) at the surface of an infected cell
does not permit the establishment of an efficient immune attack. Such a
strategy appears to have been adopted by animal oncoviruses such as
bovine leukemia virus (BLV) and human T-cell leukemia virus (HTLV). In
BLV-infected animals, only a small fraction of the infected lymphocytes
(between 1 in 5,000 and 1 in 50,000) express large amounts of viral
proteins; the vast majority of the proviruses are repressed at the
transcriptional level. Induction of BLV transcription involves the
interaction of the virus-encoded Tax protein with the CREB/ATF factors;
the resulting complex is able to interact with three 21-bp
Tax-responsive elements (TxRE) located in the 5' long terminal repeat
(5' LTR). These TxRE contain cyclic AMP-responsive elements (CRE), but, remarkably, the "TGACGTCA" consensus is never strictly
conserved in any viral strain (e.g.,AGACGTCA,
TGACGGCA, TGACCTCA). To assess the role
of these suboptimal CREs, we introduced a perfect consensus sequence
within the TxRE and showed by gel retardation assays that the binding
efficiency of the CREB/ATF proteins was increased. However,
trans-activation of a luciferase-based reporter by Tax was
not affected in transient transfection assays. Still, in the absence of
Tax, the basal promoter activity of the mutated LTR was increased as
much as 20-fold. In contrast, mutation of other regulatory elements
within the LTR (the E box, NF-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.6977-6988.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Suboptimal Enhancer Sequences Are Required for Efficient Bovine
Leukemia Virus Propagation In Vivo: Implications for Viral
Latency
B, and glucocorticoid- or
interferon-responsive sites [GRE or IRF]) did not induce a similar
alteration of the basal transcription levels. To evaluate the
biological relevance of these observations made in vitro, the mutations
were introduced into an infectious BLV molecular clone. After injection
into sheep, it appeared that all the recombinants were infectious in
vivo and did not revert into a wild-type virus. All of them, except
one, propagated at wild-type levels, indicating that viral spread was
not affected by the mutation. The sole exception was the CRE mutant;
proviral loads were drastically reduced in sheep infected with this
type of virus. We conclude that a series of sites (NF-
B, IRF, GRE,
and the E box) are not required for efficient viral spread in the sheep
model, although mutation of some of these motifs might induce a minor
phenotype during transient transfection assays in vitro. Remarkably, a
provirus (pBLV-
21-bp) harboring only two TxRE was infectious and
propagated at wild-type levels. And, most importantly, reconstitution
of a consensus CRE, within the 21-bp enhancers increases binding of
CREB/ATF proteins but abrogates basal repression of LTR-directed
transcription in vitro. Suboptimal CREs are, however, essential for
efficient viral spread within infected sheep, although these sites are
dispensable for infectivity. These results suggest an evolutionary
selection of suboptimal CREs that repress viral expression with escape
from the host immune response. These observations, which were obtained in an animal model for HTLV-1, are of interest for oncovirus-induced pathogenesis in humans.
*
Corresponding author. Mailing address: Molecular and
Cellular Biology, Faculté Universitaire des Sciences
Agronomiques (FUSAGx), 13 avenue Maréchal Juin, 5030 Gembloux, Belgium. Phone: 32-81-622157. Fax: 32-81-613888. E-mail:
Willems.l{at}fsagx.ac.be.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»